What We do
Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve, or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including somatic and hereditary cancer, cardiac health, carrier screening, diet and weight loss, as well as drug response for specific medications including those used in pain management and mental health.
Latest Press Releases
Pathway Genomics’ Chief Financial Officer, Kamal Adawi to present at Canaccord Genuity Medical Technology & Diagnostics Forum
SAN DIEGO– October 13, 2016 — (BUSINESS WIRE)— Pathway Genomics, an innovative commercial-stage genomics company, announced today that Kamal Adawi, Chief Financial Officer, will present at the 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, which will be held at the Westin Grand Central Hotel in New York City on Thursday, November 17, 2016…
G-TAC – M3 (a Sony Company) and Pathway Genomics Partner to Market CancerIntercept™, BRCATrue® and Fitness Genetic Tests in Japan
TOKYO – July 19, 2016 — (BUSINESS WIRE) — G-TAC Co., Ltd. and M3, Inc. (an associated company of SONY) announced a strategic business partnership with Pathway Genomics to market fourteen tests including CancerIntercept™, BRCATrue®, PathwayFit®, SkinFit™ and other genetic tests through G-TAC’s genomics network of over 20,000 physicians in Japan.
SAN DIEGO, CA – May 26, 2016 – Pathway Genomics today provided an update on the clinical development program for its liquid biopsy, CancerIntercept™ Detect, a non-invasive screening test for detection of mutations that have been associated with cancer. Pathway Genomics researchers have initiated a clinical trial for the detection of thyroid cancer – the company’s third ongoing study for the technology. The company also announced the publication of two abstracts in the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting Proceedings.
Latest Blog Posts
10/13/2016 | Genetics 101
If you have a strong family history of breast cancer but tested negative for BRCA1 and BRCA2, there’s another key gene you may want to have checked – PALB2. A study published in The New England Journal of Medicine found that women under 40 years old with mutations in the PALB2 gene may have 8-9 times higher risk of developing breast cancer during their lifetime as compared to the general population.
09/21/2016 | Genetics 101
Psoriasis is a chronic, non-contagious skin disorder and is among the most widespread autoimmune, genetic diseases in the United States. According to the National Institute of Health in the US, between 5.8 and 7.5 million Americans have psoriasis.
08/29/2016 | Genetics 101
With the conclusion of the Rio Olympics I’m sure you are still astounded by the athleticism of the athletes. How many of you watching thought; that athlete must have impeccable genetics to be able to run/swim/jump as swiftly as they do.
Of course athletes have dedication, many hours of training, consistency and perseverance. But one very significant contributing element is their genetic makeup. Some of you may never have been able to sprint or jump. There’s a substantial reason for that. You may not obtain the genetic makeup that allows you the inherit ability to sprint or jump proficiently.
The following positions are currently available. If you are applying for one of these positions, please submit your resume and cover letter along with your salary requirement by e-mail to firstname.lastname@example.org. Please include the title of the position you are applying to in the subject line. Pathway Genomics is an Equal Employment Opportunity and Affirmative Action employer.